Akadeum Life Sciences Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series AA
- Latest Deal Amount
-
$2.13M
- Investors
-
30
Akadeum Life Sciences General Information
Description
Developer of bio-separation products designed to facilitate the removal of target cells from biological samples. The company's products are based on buoyancy-activated cell sorting that uses microscopic micro-bubbles to capture target cells and quickly float them to the surface of a liquid sample for removal, enabling medical practitioners to use those cells for performing downstream testing and analysis with increased efficiency.
Contact Information
Website
www.akadeum.comCorporate Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
Corporate Office
- 674 South Wagner Road
- Ann Arbor, MI 48103
- United States
Akadeum Life Sciences Timeline
Akadeum Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC (Series AA) | 09-Jul-2026 | $2.13M | Completed | Generating Revenue | ||
| 13. Later Stage VC (Series BB) | 25-Apr-2025 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 23-May-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 16-May-2023 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 22-Feb-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 29-Sep-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 11-May-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A1) | 01-Feb-2019 | Completed | Generating Revenue | |||
| 6. Seed Round | 28-Sep-2017 | $1.49M | $2.64M | Completed | Startup | |
| 5. Seed Round | 31-Jul-2015 | $1M | $1.15M | Completed | Startup |
Akadeum Life Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series AA-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Akadeum Life Sciences Comparisons
Industry
Financing
Details
Akadeum Life Sciences Competitors (38)
One of Akadeum Life Sciences’s 38 competitors is LevitasBio, a Venture Capital-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LevitasBio | Venture Capital-Backed | Hayward, CA | ||||
| Mission Bio | Venture Capital-Backed | San Francisco, CA | ||||
| Aviva Systems Biology | Formerly VC-backed | San Diego, CA | ||||
| Cytena | Formerly VC-backed | Freiburg, Germany | ||||
| StemExpress | Corporation | Folsom, CA |
Akadeum Life Sciences Patents
Akadeum Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4646244-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Pending | 14-Feb-2023 | ||
| US-12099050-B2 | Method and system for partially or fully automated buoyancy-assisted separation | Active | 14-Feb-2023 | ||
| US-20240272139-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Active | 14-Feb-2023 | ||
| US-20240402150-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Pending | 14-Feb-2023 | ||
| WO-2024173590-A1 | Method and system for partially or fully automated buoyancy-assisted separation | Inactive | 14-Feb-2023 | G01N33/491 |
Akadeum Life Sciences Signals
Akadeum Life Sciences Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NYBC Ventures | Corporate Venture Capital | Minority | ||
| Innovation Partnerships | Venture Capital | Minority | ||
| Michigan Biomedical Venture Fund | Venture Capital | Minority | ||
| Western Technology Investment | Venture Capital | Minority | ||
| Arboretum Ventures | Venture Capital | Minority |
Akadeum Life Sciences FAQs
-
When was Akadeum Life Sciences founded?
Akadeum Life Sciences was founded in 2014.
-
Where is Akadeum Life Sciences headquartered?
Akadeum Life Sciences is headquartered in Ann Arbor, MI.
-
What is the size of Akadeum Life Sciences?
Akadeum Life Sciences has 15 total employees.
-
What industry is Akadeum Life Sciences in?
Akadeum Life Sciences’s primary industry is Discovery Tools (Healthcare).
-
Is Akadeum Life Sciences a private or public company?
Akadeum Life Sciences is a Private company.
-
What is the current valuation of Akadeum Life Sciences?
The current valuation of Akadeum Life Sciences is .
-
What is Akadeum Life Sciences’s current revenue?
The current revenue for Akadeum Life Sciences is .
-
How much funding has Akadeum Life Sciences raised over time?
Akadeum Life Sciences has raised $57.5M.
-
Who are Akadeum Life Sciences’s investors?
NYBC Ventures, Innovation Partnerships, Michigan Biomedical Venture Fund, Western Technology Investment, and Arboretum Ventures are 5 of 30 investors who have invested in Akadeum Life Sciences.
-
Who are Akadeum Life Sciences’s competitors?
LevitasBio, Mission Bio, Aviva Systems Biology, Cytena, and StemExpress are some of the 38 competitors of Akadeum Life Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process